Aemetis (NASDAQ:AMTX – Get Free Report) is expected to release its earnings data before the market opens on Thursday, March 6th. Analysts expect Aemetis to post earnings of ($0.46) per share and revenue of $80.59 million for the quarter.
Aemetis Stock Performance
NASDAQ AMTX opened at $1.67 on Tuesday. Aemetis has a fifty-two week low of $1.62 and a fifty-two week high of $7.03. The stock has a 50 day simple moving average of $2.37 and a two-hundred day simple moving average of $2.73. The stock has a market cap of $85.43 million, a P/E ratio of -0.74 and a beta of 1.44.
Analyst Upgrades and Downgrades
Several research firms have weighed in on AMTX. StockNews.com upgraded Aemetis to a “sell” rating in a report on Wednesday, February 5th. HC Wainwright reissued a “buy” rating and issued a $28.00 target price on shares of Aemetis in a research report on Monday, December 23rd. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $14.56.
About Aemetis
Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.
Further Reading
- Five stocks we like better than Aemetis
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- Insider Selling Explained: Can it Inform Your Investing Choices?
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Receive News & Ratings for Aemetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aemetis and related companies with MarketBeat.com's FREE daily email newsletter.